Index Performance
Index performance of price, total return net and total return gross indices is displayed in realtime.
| Period | Price | Total Return Net | Total Return Gross |
| Year-to-Date Performance | 24.40% | 24.97% | 25.17% |
| 1-Year Performance | 17.04% | 17.63% | 17.84% |
| 3-Year Performance | 29.60% | 31.70% | 32.48% |
| 5-Year Performance | 16.43% | 19.20% | 20.27% |
| Since Inception (29 Sep 2000) | 224.08% | 234.86% | 353.14% |
Index Records
Index highs and lows of price, total return net and total return gross indices are displayed in realtime.
| Period | Price | Total Return Net | Total Return Gross |
| All Time High/Low | 3,367.70 / 312.69 | 3,407.55 / 312.71 | 4,611.19 / 1,000.00 |
| 52-Weeks High/Low | 3,298.58 / 2,421.18 | 3,407.55 / 2,490.21 | 4,611.19 / 3,364.26 |
| Quarter High/Low | 3,298.58 / 2,681.94 | 3,407.55 / 2,768.67 | 4,611.19 / 3,745.68 |
| Month High/Low | 3,298.58 / 3,059.40 | 3,407.55 / 3,158.35 | 4,611.19 / 4,272.86 |
Index Correlation and Volatility
Index correlation to selected index peers and index volatility are updated daily.
| Index Correlation | |
| MSCI ACWI Biotechnology | 0.9006 |
| DJ US Biotechnology TSM | 0.9377 |
| Index Volatility | |
| 22-day Volatility | 12.57 |
| 250-day Volatility | 20.01 |
Component Performance
Displayed are the best and worst index components over a selected period of time. Data is updated daily.
| Best 5 Components | 1-Year | Year-to-Date | 1-Day |
| ALEXION PHARMACEUTICALS INC | -4.64% | 12.47% | -1.53% |
| AMGEN INC | 22.93% | 23.88% | 0.07% |
| BIOGEN INC | -8.62% | -2.89% | -1.67% |
| BIOMARIN PHARMACEUTICAL INC | -14.70% | -7.49% | -0.83% |
| CHARLES RIVER LABORATORIES | 13.53% | 29.21% | 0.01% |
| GILEAD SCIENCES INC | 3.85% | 11.49% | 1.04% |
| ILLUMINA INC | -2.53% | 6.88% | -1.95% |
| INCYTE CORP | 44.71% | 49.28% | -0.83% |
| REGENERON PHARMACEUTICALS | -0.58% | 0.01% | 1.59% |
| SEATTLE GENETICS INC | 82.70% | 96.51% | -2.32% |
| UNITED THERAPEUTICS CORP | -15.76% | -15.07% | -0.58% |
| VERTEX PHARMACEUTICALS INC | 27.00% | 32.76% | -0.12% |
| ALNYLAM PHARMACEUTICALS INC | 54.69% | 62.93% | -2.50% |
| GRIFOLS SA-ADR | 22.25% | 25.32% | -1.13% |
| ALLERGAN PLC | 27.14% | 42.39% | 0.55% |
| BLUEBIRD BIO INC | -17.03% | -12.33% | 1.49% |
| IONIS PHARMACEUTICALS INC | 14.35% | 14.11% | -1.94% |
| NEUROCRINE BIOSCIENCES INC | 32.05% | 58.59% | -0.35% |
| QIAGEN NV | 18.15% | 20.17% | -0.67% |
| IQVIA HOLDINGS INC | 18.39% | 23.82% | -1.56% |
| EXACT SCIENCES CORP | 22.51% | 34.98% | -0.15% |
| SAREPTA THERAPEUTICS INC | -18.84% | -7.04% | -4.45% |
| BEIGENE LTD-ADR | 31.51% | 28.28% | -1.34% |
| GUARDANT HEALTH INC | 61.82% | 88.29% | -3.49% |
| Worst 5 Components | 1-Year | Year-to-Date | 1-Day |
| ALEXION PHARMACEUTICALS INC | -4.64% | 12.47% | -1.53% |
| AMGEN INC | 22.93% | 23.88% | 0.07% |
| BIOGEN INC | -8.62% | -2.89% | -1.67% |
| BIOMARIN PHARMACEUTICAL INC | -14.70% | -7.49% | -0.83% |
| CHARLES RIVER LABORATORIES | 13.53% | 29.21% | 0.01% |
| GILEAD SCIENCES INC | 3.85% | 11.49% | 1.04% |
| ILLUMINA INC | -2.53% | 6.88% | -1.95% |
| INCYTE CORP | 44.71% | 49.28% | -0.83% |
| REGENERON PHARMACEUTICALS | -0.58% | 0.01% | 1.59% |
| SEATTLE GENETICS INC | 82.70% | 96.51% | -2.32% |
| UNITED THERAPEUTICS CORP | -15.76% | -15.07% | -0.58% |
| VERTEX PHARMACEUTICALS INC | 27.00% | 32.76% | -0.12% |
| ALNYLAM PHARMACEUTICALS INC | 54.69% | 62.93% | -2.50% |
| GRIFOLS SA-ADR | 22.25% | 25.32% | -1.13% |
| ALLERGAN PLC | 27.14% | 42.39% | 0.55% |
| BLUEBIRD BIO INC | -17.03% | -12.33% | 1.49% |
| IONIS PHARMACEUTICALS INC | 14.35% | 14.11% | -1.94% |
| NEUROCRINE BIOSCIENCES INC | 32.05% | 58.59% | -0.35% |
| QIAGEN NV | 18.15% | 20.17% | -0.67% |
| IQVIA HOLDINGS INC | 18.39% | 23.82% | -1.56% |
| EXACT SCIENCES CORP | 22.51% | 34.98% | -0.15% |
| SAREPTA THERAPEUTICS INC | -18.84% | -7.04% | -4.45% |
| BEIGENE LTD-ADR | 31.51% | 28.28% | -1.34% |
| GUARDANT HEALTH INC | 61.82% | 88.29% | -3.49% |
